• April 13, 2012
    PARIS, France--Four European academic research groups, together with Pfizer Animal Health, have forged a new research consortium to combat uterine disease - a problem that costs the EU dairy industry about €1.4billion annually. Called the IPUD research project (Integrated systems approach for Preventing Uterine Disease in dairy cattle), the collaboration involves academic research groups at Swansea University, the University ofmore...
  • April 11, 2012
    RALEIGH, N.C.--Poultry science students at the University of Arkansas have been awarded a $3,000 grant for their initiative which aims to improve the public’s understanding of the poultry industry. The award is courtesy of Reach Teach Learn―a Pfizer Animal Health Global Poultry project―which invited agriculture students across the U.S. to demonstrate how they could open a dialogue with consumers and enhance the perception of the poultrymore...
  • March 29, 2012
    LONDON, England--The Chinese Veterinary Medical Association (CVMA) and the International Veterinary Collaboration for China (IVCC), a consortium of leading veterinary medical schools in the United States and United Kingdom and Pfizer Animal Health, announced the signing of a memorandum of understanding through which the CVMA will collaborate with the IVCC to advance veterinary medical education and animal health in mainland Chinamore...
  • February 27, 2012
    MADISON, N.J.--Fostera™ PRRS*, a modified-live vaccine for growing pigs from Pfizer Animal Health, brings a new high standard of innovation to the costly battle against porcine reproductive and respiratory syndrome (PRRS) respiratory disease. Demonstrating its commitment to high standards, Pfizer Animal Health's research and development team made a significant breakthrough. They created unique cell lines that were able to express amore...
  • January 27, 2012
    Dozulé, Normandy, France--Pfizer Animal Health and The Hippolia Foundation announced today the formation of a strategic partnership to advance equine health through research and educational programmes. The Hippolia Foundation – a network of leading French equine institutions together with international partners – will collaborate with Pfizer to accelerate advancement in innovation on the diagnosis, treatment and prevention of equinemore...
  • January 25, 2012
    DURHAM, N.C.--Pfizer Animal Health Global Poultry’s new in ovo vaccination device, which was officially unveiled at IPE, could help improve operations at smaller hatcheries, according to one of the device’s trial participants. Marciano Régis Tonus, agribusiness director of Frango Seva, in Pato Branco, Brazil, spent a month trialling the new Embrex® Inovoject® m, a semi-automated device designed specifically for hatcheries that do notmore...
  • November 14, 2011
    RALEIGH, N.C.--Some ag student out there has a big idea about how to promote ag. The Reach Teach Learn Project will make it happen. Hundreds of youth study on ag college campuses every day, passionate about agriculture and ready to tell their story. The Reach Teach Learn Project provides a vehicle for students to channel that passion into advocacy for agriculture. In its fourth year, the Reach Teach Learn Project—sponsored by Pfizermore...
  • November 8, 2011
    KALAMAZOO, Mich.--Pfizer Animal Health affirmed its commitment to innovation in equine health with the opening today of the Pfizer Animal Health Equine Research Center in Richland, Mich. The center, the culmination of a $7 million investment, expands Pfizer Animal Health’s global research and development network headquarters in Kalamazoo, Mich., and will serve as the worldwide hub for research and development of equine vaccines and novelmore...
  • November 7, 2011
    The benefits of in ovo vaccination are now within the reach of many more hatcheries worldwide, thanks to the development of a new compact device. Embrex* Inovoject* m is a semi-automated in ovo vaccination system from Pfizer Animal Health Global Poultry designed for those hatcheries that do not have a large enough footprint or throughput to justify the installation of a full-size Embrex Inovoject. The new device allows thesemore...
  • November 3, 2011
    JILIN--Pfizer Animal Health, a business unit of Pfizer (NYSE: PFE), and Jilin Guoyuan Animal Health Co., Ltd., announced today the establishment of the joint venture Jilin Pfizer Guoyuan Animal Health Co., Ltd. The joint venture, which has been granted a license by local Chinese government authorities, formalizes the strategic agreement signed on September 8 to develop, manufacture, and distribute animal vaccines in China. Terms of the agreementmore...